Table 1.
Cervical cancer and HIV intervention scenarios beginning in 2021.
Fig 1.
Median projected cervical cancer incidence rates per 100,000 women aged 15+ for the general population (A) and by HIV status (B) over time under simulated intervention scenarios. The data point in red was estimated by adjusting South Africa Globocan 2018 [1] rates by age to take into account higher HIV prevalence in KwaZulu-Natal, weighting rates by the median modeled population age distribution in 2018, and then summing to get an estimate of the cervical cancer incidence rate for all women aged 15+ in KwaZulu-Natal.
Fig 2.
Median proportion of cervical cancer cases among women living with HIV aged 15+ and HIV prevalence among women aged 15+ over time under simulated intervention scenarios.
Table 2.
Cervical cancer and HIV outcomes over time under simulated intervention scenarios with uncertainty ranges [URs].
Fig 3.
Median percent difference in simulated cervical cancer and HIV outcomes in 2071 with each scenario compared to the baseline scenario in 2071 among women aged 15+.